TY - JOUR
T1 - Deletion of the microRNA-degrading nuclease, translin/trax, prevents pathogenic vascular stiffness
AU - Tuday, Eric
AU - Nomura, Yohei
AU - Ruhela, Deepa
AU - Nakano, Mitsunori
AU - Fu, Xiuping
AU - Shah, Aparna
AU - Roman, Barbara
AU - Yamaguchi, Atsushi
AU - An, Steven S.
AU - Steenbergen, Charles
AU - Baraban, Jay M.
AU - Berkowitz, Dan E.
AU - Das, Samarjit
N1 - Funding Information:
This work was supported by American Heart Association Grant 14SDG18890049; Maryland Stem Cell Research Fund Grant Mscrfd-4313 (to S. Das); National Institutes of Health Grants 5-R01-HL-039752 (to C. Steen-bergen), T32-HL007227-42 (to E. Tuday), and DA-00266; Johns Hopkins Synergy Award (to J. M. Baraban); Magic That Matters (to E. Tuday, J. M. Baraban, and S. Das); and Stimulating and Advancing Anesthesiology & Critical Care Medicine Research (to D. Ruhela, and S. Das).
Publisher Copyright:
Copyright © 2019 the American Physiological Society.
PY - 2019
Y1 - 2019
N2 - Vascular stiffness plays a key role in the pathogenesis of hypertension. Recent studies indicate that the age-associated reduction in miR-181b levels in vascular smooth muscle cells (VSMCs) contributes to increased vascular stiffness. As these findings suggest that inhibiting degradation of miR-181b might prevent vascular stiffening, we have assessed whether the microRNA-degrading translin/trax (TN/TX) complex mediates degradation of miR-181b in the aorta.We found that TN-/- mice display elevated levels of miR-181b expression in the aorta. Therefore, we tested whether TN deletion prevents vascular stiffening in a mouse model of hypertension, induced by chronic high-salt intake (4%NaCl in drinking water for 3 wk; HSW). TN-/- mice subjected to HSW stress do not show increased vascular stiffness, as monitored by pulse wave velocity and tensile testing. The protective effect of TN deletion in the HSW paradigm appears to be mediated by its ability to increase miR-181b in the aorta since HSW decreases levels of miR- 181b in WT mice, but not in TN KO mice. We demonstrate for the first time that interfering with microRNA degradation can have a beneficial impact on the vascular system and identify the microRNAdegrading TN/TX RNase complex as a potential therapeutic target in combatting vascular stiffness. NEW & NOTEWORTHY While the biogenesis and mechanism of action of mature microRNA are well understood, much less is known about the regulation of microRNA via degradation. Recent studies have identified the protein complex, translin(TN)/trax(TX), as a microRNAdegrading enzyme. Here, we demonstrate that TN/TX is expressed in vascular smooth muscle cells. Additionally, deletion of the TN/TX complex selectively increases aortic miR-181b and prevents increased vascular stiffness caused by ingestion of high-salt water. To our knowledge, this is first report describing the role of a microRNA RNAse in cardiovascular biology or pathobiology.
AB - Vascular stiffness plays a key role in the pathogenesis of hypertension. Recent studies indicate that the age-associated reduction in miR-181b levels in vascular smooth muscle cells (VSMCs) contributes to increased vascular stiffness. As these findings suggest that inhibiting degradation of miR-181b might prevent vascular stiffening, we have assessed whether the microRNA-degrading translin/trax (TN/TX) complex mediates degradation of miR-181b in the aorta.We found that TN-/- mice display elevated levels of miR-181b expression in the aorta. Therefore, we tested whether TN deletion prevents vascular stiffening in a mouse model of hypertension, induced by chronic high-salt intake (4%NaCl in drinking water for 3 wk; HSW). TN-/- mice subjected to HSW stress do not show increased vascular stiffness, as monitored by pulse wave velocity and tensile testing. The protective effect of TN deletion in the HSW paradigm appears to be mediated by its ability to increase miR-181b in the aorta since HSW decreases levels of miR- 181b in WT mice, but not in TN KO mice. We demonstrate for the first time that interfering with microRNA degradation can have a beneficial impact on the vascular system and identify the microRNAdegrading TN/TX RNase complex as a potential therapeutic target in combatting vascular stiffness. NEW & NOTEWORTHY While the biogenesis and mechanism of action of mature microRNA are well understood, much less is known about the regulation of microRNA via degradation. Recent studies have identified the protein complex, translin(TN)/trax(TX), as a microRNAdegrading enzyme. Here, we demonstrate that TN/TX is expressed in vascular smooth muscle cells. Additionally, deletion of the TN/TX complex selectively increases aortic miR-181b and prevents increased vascular stiffness caused by ingestion of high-salt water. To our knowledge, this is first report describing the role of a microRNA RNAse in cardiovascular biology or pathobiology.
KW - Hypertension
KW - MiR-181b
KW - MiRNA-degradation
KW - Translin/trax complex
KW - Vascular stiffness
UR - http://www.scopus.com/inward/record.url?scp=85074553089&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074553089&partnerID=8YFLogxK
U2 - 10.1152/AJPHEART.00153.2019
DO - 10.1152/AJPHEART.00153.2019
M3 - Article
C2 - 31625778
AN - SCOPUS:85074553089
SN - 0363-6135
VL - 317
SP - H1116-H1124
JO - American Journal of Physiology - Heart and Circulatory Physiology
JF - American Journal of Physiology - Heart and Circulatory Physiology
IS - 5
ER -